Evidence-based indications for the use of PET-CT in the United Kingdom 2016

Reference: 
BFCR(16)3
Date: 
2016
Review Date: 
2019

Since its introduction to clinical practice, positron emission tomography-computed tomography (PET-CT) has become a key investigative tool in the assessment of cancer and non-cancer medical conditions. Now in its third edition, the 2016 version of these guidelines builds on the evidence cited in earlier editions.

New indications and key references are highlighted in red ink for ease of identification.